YU170475A - Process for preparing galenic formulations - Google Patents

Process for preparing galenic formulations

Info

Publication number
YU170475A
YU170475A YU01704/75A YU170475A YU170475A YU 170475 A YU170475 A YU 170475A YU 01704/75 A YU01704/75 A YU 01704/75A YU 170475 A YU170475 A YU 170475A YU 170475 A YU170475 A YU 170475A
Authority
YU
Yugoslavia
Prior art keywords
galenic formulations
preparing
preparing galenic
formulations
galenic
Prior art date
Application number
YU01704/75A
Inventor
J Franz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of YU170475A publication Critical patent/YU170475A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
YU01704/75A 1974-07-05 1975-07-02 Process for preparing galenic formulations YU170475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH931274 1974-07-05

Publications (1)

Publication Number Publication Date
YU170475A true YU170475A (en) 1984-02-29

Family

ID=4350618

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01704/75A YU170475A (en) 1974-07-05 1975-07-02 Process for preparing galenic formulations

Country Status (14)

Country Link
JP (1) JPS5132724A (en)
AU (1) AU8280175A (en)
BE (1) BE831042A (en)
DE (1) DE2528516A1 (en)
ES (1) ES439113A1 (en)
FR (1) FR2276832A1 (en)
GB (1) GB1518683A (en)
HU (1) HU170215B (en)
IL (1) IL47634A (en)
NL (1) NL7507798A (en)
NZ (1) NZ178011A (en)
SE (1) SE7507414L (en)
YU (1) YU170475A (en)
ZA (1) ZA754304B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163810A (en) * 1978-06-14 1979-12-26 Mundipharma Ag Gel composition for local coating
JPS56159310A (en) * 1980-05-14 1981-12-08 Showa Denko Kk Preparation of monofilament having high strength and knot strength
FR2483235A1 (en) * 1980-05-28 1981-12-04 Fabre Sa Pierre TOPICAL COMPOSITIONS CONTAINING RYE AND VINCA ROSEA ERGOT ALKALOIDS FOR THE TREATMENT OF HYPERSEBORRHOES
JPS59216825A (en) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd External drug for transcutaneous absorption
US4752612A (en) * 1983-07-01 1988-06-21 Nitto Electrical Industrial Co., Ltd. Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
JPS6013720A (en) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd Percutaneous administration of physiological activator using adjuvant, solvent and diol modulator
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPH0735331B2 (en) * 1986-01-16 1995-04-19 久光製薬株式会社 External gel formulation
JPH0735332B2 (en) * 1986-02-25 1995-04-19 久光製薬株式会社 Cream formulation for external use
JPH0759519B2 (en) * 1987-02-23 1995-06-28 株式会社資生堂 Transdermal absorption enhancer and external preparation for skin containing the same
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
DE3710216A1 (en) * 1987-03-27 1988-10-06 Rentschler Arzneimittel USE OF DIHYDROERGOTAMINE AND ITS SALTS FOR LOCAL TREATMENT OF TROPHIC DISORDERS
JPH0720866B2 (en) * 1987-05-15 1995-03-08 三生製薬株式会社 Transdermal preparation containing eperisone or tolperisone or their salts
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
CH679119A5 (en) * 1988-05-13 1991-12-31 Sandoz Ag
GB2230444B (en) * 1989-04-19 1993-12-08 Ritchie Swanson John Therapeutic compositions.
US5219877A (en) * 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
EP0532546B1 (en) * 1990-05-10 1998-03-18 Bechgaard International Research And Development A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
PT730441E (en) * 1993-11-12 2002-06-28 Procter & Gamble DISCHARGING COMPOSITIONS CONTAINING SALICYLIC ACID AND ZWITERIONIC COMPOUNDS
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6005135A (en) * 1996-03-21 1999-12-21 Exxon Chemical Patents Inc. Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
DK1666026T4 (en) † 1999-02-08 2015-05-04 Intarcia Therapeutics Inc Non-aqueous single-phase biocompatible, viscous feeders and processes for their preparation
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
MX2008014870A (en) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Two-piece, internal-channel osmotic delivery system flow modulator.
EP2363112B8 (en) 2006-08-09 2018-11-21 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
EP3011954A1 (en) * 2007-11-22 2016-04-27 Medrx Co., Ltd. External preparation composition comprising fatty acid-based ionic liquid as active ingredient
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
AU2010298733B2 (en) 2009-09-28 2014-10-09 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
JP2012020991A (en) 2010-06-16 2012-02-02 Takasago Internatl Corp Transdermal absorption promoter, and external skin formulation thereof
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP5820207B2 (en) * 2011-09-13 2015-11-24 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
JP5820206B2 (en) * 2011-09-13 2015-11-24 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3213769A4 (en) 2014-10-30 2018-02-21 Asahi Kasei Kabushiki Kaisha Transdermal-absorption-promoter and transdermal-absorption-promoting supplement
EP3302354B1 (en) 2015-06-03 2023-10-04 i2o Therapeutics, Inc. Implant placement systems
RU2760007C2 (en) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Polypeptides selective to glucagon receptors and their application methods
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL307966A (en) 2017-01-03 2023-12-01 Intarcia Therapeutics Inc Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug

Also Published As

Publication number Publication date
DE2528516A1 (en) 1976-01-22
NL7507798A (en) 1976-01-07
FR2276832B1 (en) 1978-10-06
JPS5132724A (en) 1976-03-19
NZ178011A (en) 1978-07-28
FR2276832A1 (en) 1976-01-30
SE7507414L (en) 1976-01-07
BE831042A (en) 1976-01-05
AU8280175A (en) 1977-01-13
ZA754304B (en) 1977-02-23
GB1518683A (en) 1978-07-19
IL47634A (en) 1978-07-31
ES439113A1 (en) 1977-10-16
HU170215B (en) 1977-04-28
IL47634A0 (en) 1975-10-15

Similar Documents

Publication Publication Date Title
YU170475A (en) Process for preparing galenic formulations
CS183829B2 (en) Process for preparing thienamycine
HU174074B (en) Process for preparing 4-polyalkoxy-phenyl-2-pyrrolidone
JPS51125466A (en) Process for preparing graftcopolymer
HU171059B (en) Process for preparing pyridazinyl-benzimidazoles
YU328375A (en) Process for preparing aryl-imidazolyl-ketones
HU171231B (en) Process for preparing iodo-polyvinyl-pyrrolidone
HU172615B (en) Process for preparing substituted phenyl-alkyl-amines
CS187466B2 (en) Process for preparing 2-arylamino-2-imidazolines
CS189730B2 (en) Process for preparing o-cyanazodyes
CS191290B2 (en) Process for preparing aminoalkylphenyletheres
HU175380B (en) Process for preparing thiol-carbamates
HU171837B (en) Process for preparing 14 alpha-hydroxy-steroids
CS193518B2 (en) Process for preparing moenomycine
MW1074A1 (en) Process for preparing 3-fluorocephalosporins
CS188259B2 (en) Process for preparing 2-anilinooxazoles
GB1486844A (en) Process for preparing 7beta-acylamino-7alpha-alkoxy-cephalosporins
CS188984B2 (en) Process for preparing 3-fluorbenzodiazepines
HU175228B (en) Process for preparing 6-methyl-8beta-nitromethyl-ergoline
HU172658B (en) Process for preparing benzene-sulphonyl-carbamides
HU172273B (en) Process for preparing 2-deutero-3-fluoro-dl-alanine
ZA75634B (en) Process for preparing injectionable compositions
JPS51125257A (en) Process for preparing 111deoxyy omegaapentanolprostagladine
CS189725B2 (en) Process for preparing substituted 1-phenoxy-3-p-hydroxyphenetylamino-2-hydroxyalkanoles
YU350674A (en) Process for preparing substituted s-alkyl-thiocarbamate